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1. Introduction 
Pregnancy is a high risk condition for developing iodine-deficient disorders (IDD), mainly 
in circumstances of reduced iodine supply, due to the fact that during this physiological 
period of life the requirement of thyroid hormones increases with 30-50% (Alexander et al., 
2012, Leung et al. 2011). Besides goiter, thyroid dysfunctions may develop. When the 
compensatory mechanisms become insufficient subclinical or overt hypothyroidism occur. 
Hypothyroidism may cause maternal and fetal complications: miscarriage, abortion, 
premature delivery, birth complications, neonatal respiratory distress syndrome, intellectual 
disabilities in offsprings including cretinism, growth retardation (Boyages, 1993; Pharoah et 
al., 1971, de Escobar et al., 2007; Cao et al., 1994). Thus hypothyroidism must be recognized 
and treated as early as possible, which would be before pregnancy, to avoid the above 
mentioned complications. Screening of pregnant women and of those who intend to become 
pregnant would be an adequate method for this purpose. 
However, the screening for thyroid diseases in pregnant and lactating women is still an 
issue under debate. The inclusion criteria of the screening process are mostly disputed. 
Some authors consider the screening of high-risk pregnant women for thyroid disorders 
sufficient, others suggest universal screening program (the assessment of all women during 
pregnancy for thyroid conditions), mostly in iodine deficient areas. Iodine and thyroid 
hormones are essential for normal fetal and neonatal development, and their increased 
requirement in pregnancy rises the frequency of goiter and thyroid dysfunctions. These 
diseases are often oligosymptomatic and can easily remain undiagnosed, consequently fetal 
developmental impairments of different severity (even mental retardation, endemic 
cretinism) can appear in the circumstances of iodine and thyroid hormone deficiency.  
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Universal screening in pregnancy may be indicated in iodine deficient regions, but it 
represents a serious financial effort which was not considered justified by the evidences 
until 2007. Therefore, targeted case finding during early pregnancy, i.e. screening for thyroid 
diseases in high-risk pregnant women was recommended. This high-risk population group 
comprises pregnant women with history of hyper-/hypothyroidism, postpartum thyroiditis, 
thyroid surgery, previous head or neck radiation therapy, and miscarriage or preterm 
delivery, family history of thyroid disease, presence of goiter and/or thyroid antibodies, 
symptoms/clinical sings suggesting hyper-/hypothyroidism (including anemia, 
hypercholesterolemia, hyponatremia), type I diabetes and other autoimmune diseases 
(Endocrine Society’s Clinical Guideline, 2007). 
Iodine deficiency in Romania was confirmed by Milcu about 50-60 years ago (Milcu, 1956). 
The use of iodized alimentary salt has been introduced as a prophylactic method in our 
country since 1948 (15-25mg potassium iodide or 10mg potassium iodate per kg salt). From 
1956 a supplementary iodine prophylaxis was started by administration of potassium iodide 
tablets (1mg KI/tb.) to school-age children and pregnant women.  
The iodine status of our region, Mureş County, has been periodically assessed by a team of 
endocrinologists from the Endocrinology Clinic Târgu Mureş since 1960-70. From the 
geographic and epidemiologic point of view Mureş County is a 6,700 square km large hilly-
mountainous region in the Transylvanian Basin, located in the centre of Romania, crossed 
by the river Mureş. Its estimated population is about 600,000, with a light variation in the 
last decades: the number of inhabitants was 614,000 in 1984, with a mild increase to 620,500 
until 1990, followed by a slow decrease to 579,000 in 2007. These data are provided by the 
epidemiologic registers of National Institute of Statistics based on the censuses of 
population and housing realized in Romania (Romanian National Institute of Statistics, 
2012). 
 In 2000 Balázs et al. reported in a study the assessment of iodine deficiency in the 
hydrographic basin of the superior and middle part of river Mureş, including the collected 
data of 508 children in their work: 26.97% (137) from urban and 73.03% (371) from rural 
localities. The thyroid volume was evaluated clinically and ultrasonographically. The 
majority of rural localities presented mild and the others moderate iodine-deficiency. The 
county town, Târgu Mureş was found iodine-sufficient. The mean urinary iodine excretion 
was 100.22µg/L, but with large inter-individual variations (SD: ± 73.37). This study 
emphasized the great frequency of small goiters in rural localities compared to their more 
reduced frequency in cities (Balázs et al., 2000/a). 
Our studies performed during 2001-2004 (by the examination of urinary iodine content, 
thyroid ultrasound in school-age children and pregnant women, neonatal TSH screening) 
have confirmed that Mureş County was constantly a mild/moderate iodine deficient 
geographic area (Kun et al., 2003). During 2001-2003 we observed elevated serum TSH-
values (above 10mIU/L, according to the criterion of WHO) in 8.23% out of 2,454 studied 
newborns, with a mean TSH-level of 19.81 ± 12.63mIU/L (Szántó et al., 2007).  
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According to these data is obvious that Mureş County, during the last decades of 20th 
century and beginning of the 21st century was characterized as a moderate/mild iodine 
deficient area, thus an extensive screening of thyroid disturbances in pregnant women could 
be indicated, but it was not performed for financial reasons. In these circumstances we 
started a targeted screening in pregnant women with history of thyroid diseases and 
gestational complications (previous miscarriage, preterm or post-term delivery, postpartum 
anemia), as well as suggestive clinical signs/symptoms for thyroid dysfunctions. 
Extended studies realized during 2002-2004 have shown a moderate iodine deficiency in the 
majority (80%) of Romanian counties (mainly in rural areas), the prevalence of endemic 
goiter being between 0-40% and low urinary iodine excretion at 2/3 in the examined persons 
(Simescu et al., 2006). 
In order to ameliorate this national endemic problem a Romanian governmental decision 
(no. 568/5 June 2002) regarding the universal alimentary salt-iodization decided the release 
of alimentary salt with increased iodine-content on the market (34 ± 8.5mg KIO3/kg). This 
Decision was implemented into practice in December 2003, and in 2004 the mandatory use 
of iodized salt in baking industry was disposed in all 41 counties, both in households and 
bakeries (Second National Conference for the Elimination of Iodine Deficiency Disorders, 
2005; Kun, 2006). Consequently, iodized salt was used in 96% of households in 2004, 
according to some authors (Simescu et al., 2006). At the same time, starting from 2002 a 
national program has begun in order to estimate the iodine status of the Romanian 
population by promulgating IDD screening programs in high risk population groups 
(newborns, school-children, pregnant women). After the implementation of universal salt-
iodization the incidence of IDD has decreased considerably in school-children in several 
counties (Simescu et al., 2006).  
After these legislative changes, during 2004-2006 we restarted neonatal screening for thyroid 
dysfunctions. Comparing screening data obtained before and after universal salt iodization 
(2001-2003 vs. 2004-2006) we did not find significant differences regarding the incidence of 
elevated TSH levels, but an important reduction of mean values was observed in the second 
period (15.63 ± 7.35mIU/L) compared to the first one (19.81 ± 12.63mIU/L, i.e. a decrease 
with 4.2mIU/L, p=0.02), pleading for the amelioration of iodine deficiency (Kun, 2006; Kun 
et al., 2007). 
In 2005-2006 the assessment of iodine status in three mountain villages showed a significant 
improvement of urinary iodine excretion (UIE) compared to data published by Balázs et al. 
(2000/b): in 1999 UIE was 56.00 ± 38.07µg/L, being normal only in 6% of the investigated 
children, mild (50-99µg/L) and moderately low (20-49µg/L) each in 44%, and under 20µg/L 
(very low) in 6%. Our results in October 2006 were improved, but still subnormal: the mean 
UIE increased to 85.37 ± 60.05µg/L, 30.8% of the children had normal values, and iodine-
deficiency related hypothyroidism had an incidence of 15% in the investigated school-
children. Thyroid ultrasound performed in these children showed diffuse goiter in 27% of 
the cases. Rural mountain areas of Mureş County known before as moderate/mild iodine 
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deficient zones have become mild-deficient ones, due to the new measures of iodine 
prophylaxis (Kun et al., 2007). 
According to our previous studies Mureş County was considered a moderate/mild iodine-
deficient area before 2003, and based on our new results this area still may be considered a 
mild iodine-deficient region, mainly in mountainous rural localities (Kun, 2006; Kun et al., 
2007; Balázs et al., 2000/b; Szántó et al., 2007), and thus iodine-prophylaxis has an important 
role in preventing IDD and its complications, including thyroid dysfunctions. 
The main cause of iodine deficiency in most rural localities of Mureş County is their 
localization on hilly-mountainous geographical regions, composition of the land and water 
(Mureş river and its affluents) having low iodine content. The geographical isolation of 
mountainous places could be involved to some extent, the more isolated a locality is the 
more severe the iodine deficiency is. Larger localities and cities, such as Târgu Mureş were 
iodine sufficient places.  
The evaluation of thyroid status in pregnant women living in Mureş County has not been 
reported yet, although our targeted screening started in 2001. We consider targeted 
screening for thyroid dysfunctions in pregnant women the thyroid assessment of those 
subjects who had thyroid disease or gestational complications in the past or who recently 
have developed signs/symptoms of thyroid dysfunction or goiter during pregnancy − so we 
consider these pregnant women of high risk. 
2. Objectives 
We proposed to perform the screening of thyroid dysfunctions in pregnant women residents 
of Mureş County, being at high risk for these diseases, by determining the frequency and 
severity of hypo-/hyperthyroidism and the possible related gestational complications. 
We also wanted to assess the influence of universal salt iodization on thyroid status of this 
population group by comparing the results of targeted screening of high-risk pregnant 
women realized before (2001-2003) and after (2004-2006) taking effect the governmental 
Decision 568/2002, starting from December 2003. 
3. Material and methods 
Material. During November 2001 – February 2003 we performed a targeted screening of 
thyroid dysfunctions in 321 pregnant women living in Mureş County. This screening meant 
that TSH- and FT4-levels were measured in pregnant women with history of thyroid disease, 
clinical signs or symptoms suggestive for thyroid dysfunction or goiter, history of 
gestational complications (threatened abortion, abortion, imminent preterm birth, preterm 
delivery, miscarriage) or complications during current pregnancy. These inclusion criteria 
implied that subjects with history of thyroid condition and gestational complications firstly 
underwent endocrinological evaluation mainly in the first trimester, but others were 
screened when one of the mentioned criteria appeared, which could happen in any 
trimester, even in the third one. 
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These pregnant women were registered in endocrine out-patient units from Târgu Mureş, 
Sighişoara, Reghin and Târnăveni (all four cities of our county), as well as in the Obstetrics 
& Gynecology Clinics in Târgu Mureş (the main city of Mureş County). In some cases we 
determined the titer of thyroid peroxidase antibodies (TPO-Ab) and urinary iodine 
excretion, too.  
In order to evaluate the influence of universal iodization of alimentary salt on thyroid 
function in pregnancy, starting from 2004 we performed a second targeted screening based 
on the same inclusion criteria. Thus, during February 2004–September 2006 we screened 206 
pregnant women, then we compared the results with those obtained during 2001-2003.  
Gestational complications were assessed according to data provided by out-patient 
Endocrinology units, and medical records of pregnant women hospitalized for gestational 
complications or for delivery in the Obstetrics & Gynecology Clinics from Târgu Mureş, or 
obstetrical and neonatal sections of Hospitals from Sighişoara, Reghin and Târnăveni.  
The state of health of newborns to hypothyroid mothers was evaluated in the first 5 days of 
their life, and the distribution of neonatal complications were assessed. These data were 
compared to a group of neonates born from apparently healthy mothers: normal TSH-level 
(between 1.5-2.5mIU/L), absence of thyroid diseases and other gestational risk factors (Rh-
incompatibility, twin pregnancy, smoking etc.).  
Since 2007 a new large systematized screening of pregnant women has not been performed 
yet, further investigations being necessary depending on financial possibilities. 
Methods. Serum thyrotropin (TSH) and free-thyroxine (FT4) levels were measured from 
venous blood during the morning in all women included in the study. Third generation 
immunometric assay (ECLIA – electrochemiluminescence immunoassay) was applied at the 
Central Laboratory of Emergency Clinical Hospital Mureş County. 
Until 2006 we considered the reference range for TSH-level 0.2-3.5mIU/L in the first and 0.4-
4.0mIU/L in the second and third trimesters and in case of pathological levels we started 
specific treatment, but in 2006-2007 new normal TSH-values for pregnant women were 
adopted (Endocrine Society’s Clinical Guideline, 2007) and according to these we have re-
evaluated our data base.  
Reference ranges for serum TSH-levels were adjusted for pregnant women according to the 
gestational trimester: between 0.03–2.5mIU/L during the I., between 0.1–3.1mIU/L in the II. 
and between 0.1–3.5mIU/L in the III. trimester.  
FT4 reference range is 0.86–1.86ng/dL in the first and 0.64–1.92ng/dL in the II.–III. trimesters.  
We also assessed isolated maternal hypothyroxinaemia, which was considered by us as a 
reduced FT4 along a normal TSH level. This definition is not well delineated in the literature, 
because the reference range of TSH-level varies between large limits according to different 
authors and the gestational trimester (Vaidya et al., 2012; Glinoer & Abalovich, 2007; 
Burman, 2009). We have evaluated the TSH- and FT4-values based on the above mentioned 
normal intervals.  
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The titer of TPO-Ab was considered normal under 35IU/mL. We could measure this 
parameter randomly in a total of 46 pregnant women from the whole casuistry: 24 cases 
during 2001-2003 and 22 during 2004-2006. 
Urinary iodine excretion (UIE) measured with a semiquantitative rapid test was included 
into three ranges: <10µg%, between 10–30µg% and >30µg%, values <30µg% are considered 
low. This was determined in 69 randomized cases: 34 pregnant women included in the first 
and 35 in the second period. 
The obtained data were statistically evaluated by Students’ „t” test and χ2 test. The 
difference between parameters of two groups was considered significant, if P-value <0.05. 
Ethical considerations: Every pregnant woman was informed about screening procedures, 
the benefit of hormonal assessment, possible side effects and than the hormonal results. In 
case of thyroid dysfunction specific endocrine treatment was performed. The Research 
Ethics Committee of the University of Medicine and Pharmacy Târgu Mureş has approved 
the outline of the research process and the obtained results for publication, as all ethical 
rules were respected. 
4. Results 
During November 2001–February 2003, before the implementation of the presented 
governmental decision about universal alimentary salt-iodization we screened 321 high-risk 
pregnant women: 263 (81.9%) were euthyroid, 51 (15.88%) hypothyroid and 7 (2.18%) 
hyperthyroid. Two third (34 cases) out of the investigated hypothyroid women had 
subclinical and one third (17 cases) overt form. Among the 7 hyperthyroid pregnant women 
4 suffered of subclinical and 3 of overt form.  
 
Trimester Total cases Hypothyroidism Goiter* Hyperthyroidism 
I. 102 23 (22.5%) 41 (40.2%) 2 (1.96%) 
II. 126 15 (11.9%) 53 (42.0%) 1 (0.79%) 
III. 93 13 (13.9%) 48 (51.6%) 4 (4.3%) 
Total 321 51 (15.88%) 142 (44.23%) 7 (2.18%) 
Table 1. Thyroid state of pregnant women being in different gestational trimesters (2001-2003)  
* I. grade diffuse goiter in >80%, II. grade goiter in 14.4%, III. grade goiter in 0.6% of women. 
Only 31.8% of the subjects were screened in the first trimester, the others were detected later 
(39.2% in the II. and 29% in the III. trimester).  
We could follow-up 28 hypothyroid pregnant women having thyroid hypofunction from the 
inclusion in the screening until delivery. Half of them presented gestational complications: 2 
threatened abortions, one imminent preterm delivery, 5 preterm births, 2 prolonged 
deliveries, 2 caesarean sections for fearing fetal asphyxia, one miscarriage (hypertension, 
edema) and one pre-eclampsia. In four patients other gestational risk factors could contribute 
to the development of these complications (Rh-incompatibility, twin pregnancy, smoking). 
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We excluded these cases, so the rate of gestational complications in hypothyroid pregnant 
women without other apparent risk factors decreased to 45.8% (11/24). 
Gestational 
age at 
delivery 
Newborns of hypothyroid mothers 
Newborns of apparently 
healthy mothers 
preterm 5 
2 clinically healthy 
2 
1 clinically healthy 
1 preterm – premature grade II. 
1 preterm – premature grade I., A= 7/1’ 
1 asphyxia, A=7/1’ 
1 death by severe asphyxia* 
post-term 2 
1 clinically healthy 
– 
1 asphyxia, A=8/1’ 
born at term 21 
20 clinically healthy 
24 
23 clinically healthy 
1 asphyxia, A=8/1’(thyroidectomized 
mother, subclinical hypothyroidism) 
1 asphyxia, A=7/1’ 
Total 28  26  
Table 2. Newborns’ health status at delivery and on the first 5 days of life  
A: Apgar score; case marked with * is presented in the text 
Seven (25%) out of the 28 neonates from hypothyroid mothers were born preterm or post-
term, while 2 (7.7%) out of 26 apparently healthy women gave birth to preterm newborn. 
We observed preterm or post-term delivery in hypothyroid pregnant women significantly 
more often than in apparently healthy women (P-value: 0.07, OR: 3.7, 95%CI: 0.86−5.91), 
although these cases of hypothyroidism were mainly subclinical forms. 
In one woman diagnosed with Hashimoto’s thyroiditis in the third trimester multiple 
complications have developed: late miscarriage, severe pre-eclampsia, grade II. utero-
placental apoplexia, which needed caesarean section at the 32-33. gestational week. The 
newborn (case marked with * in Table 2.) presented acute fetal suffering (Apgar score 1/1’, 
2/5’, 3/10’). The newborn died on the 14th day of life due to severe asphyxia during birth, 
hyaline membrane disease, persistent pulmonary hypertension and pneumonia.  
One pregnant woman with overt hyperthyroidism out of the total 7 hyperthyroid cases 
during 2001-2003 developed imminent premature birth. 
TPO-Ab determined in 24 randomized cases was elevated in 3 patients (12.5%). 
During November 2001 – February 2002 urinary iodine excretion measured with semi-
quantitative method in 35 pregnant women showed values above 30µg% in 11.4%, between 
10-30µg% in 20% and <10µg% in 68.6% out of the total investigated women. Thus, UIE was 
subnormal in 88.6% of the cases. 
During February 2004–September 2006, after the legislative changes regarding universal 
iodine prophylaxis took effect we screened 206 pregnant women, their hormone status being 
presented in Table 3. 
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Thyroid function No. cases % 
Trimester 
I. II. III. 
hypothyroidism 20 9.7 13.8% 8.1 % 11.9% 
hyperthyroidism 6 2.9 5.8 % 4.3 % 0 % 
euthyroid state 180 87.4    
Total 206  
Table 3. Thyroid function of 206 high-risk pregnant women screened during 2004-2006 
Out of the 20 hypothyroid pregnant women 12 (60%) had subclinical and 8 (40%) overt 
hypofunction. Out of the 6 thyrotoxic pregnant women 4 had overt and the other 2 
subclinical disease. 
The titer of TPO-Abs determined only in 22 women was normal in all cases. Urinary iodine 
excretion measured in 34 pregnant women detected iodine deficiency in 84.2% of these 
cases. 
Half of the pregnant women with hypothyroidism detected by targeted screening during 
2004-2006 suffered from gestational complications: 5 imminent abortions, 2 imminent 
premature births, 3 miscarriages. One woman with thyroid cancer treated before pregnancy 
by thyroidectomy and insufficient substitutive-suppressive T4-therapy presented imminent 
abortion (the case was included into the previously mentioned complications). 
Three pregnant women out of the 6 hyperthyroid cases developed imminent abortion, 
hyperemesis gravidarum and imminent premature birth. All 3 had overt thyrotoxicosis (the 
majority of overt forms). 
 
Thyroid dysfunction 2001-2003 2004-2006 P-value 
Hypothyroidism 
51 cases – 15.88% 
(3 post-thyroidectomy) 
20 cases – 9.7% 
(1 PTC, thyroidectomy) 
0.049 
Overt/Subclinical 
hypothyroidism 
17:34 (=1:2) 8:12 (=2:3) 0.081 
Hyperthyroidism 7 cases – 2.18% 6 cases – 2.91% 0.44 
Overt/Subclinical 
hyperthyroidism 
3:4 2:1  
Table 4. Comparison of data obtained during 2001-2003 and 2004-2006 
PTC: papillary thyroid carcinoma 
During 2004-2006 the frequency of hypothyroidism in pregnant women has decreased 
significantly (with about 40%) compared to the previous period (2001-2003), but the ratio of 
overt/subclinical forms remained almost the same. The proportion of complications in 
hypothyroid women was similar in the two studied periods, but the total number of cases 
decreased in the second interval so the absolute number of gestational complications among 
pregnant women was reduced in the second period. Targeted case finding screening could 
Screening of High-Risk Pregnant Women  
for Thyroid Dysfunctions in a Moderately Mild Iodine-Deficient Area 53 
identify high-risk pregnant women in the first trimester only in 1/3 of the cases, the others 
being detected later. 
The rate of hyperthyroidism showed mild increase, which proved to be non-significant 
compared to 2001-2003. All hyperthyroid pregnant women with gestational complications 
suffered from overt hyperthyroidism. 
Finally we evaluated a very controversial problem: the isolated maternal hypothyroxinaemia. 
This means a low free-T4 concentration along a normal TSH-level. In our group we observed 
a few women suffering from such condition, and we considered them patients who need 
thyroid hormone replacement therapy.  
During 2001-2003 a number of 8 (2.96%) cases had isolated hypothyroxinaemia among the 
270 pregnant women with normal TSH-value: 2 in the first trimester (mean TSH: 1.10 ± 
0.66mIU/L, mean FT4: 0.69 ± 0.08ng/dL), 3 in the second (mean TSH: 1.39 ± 0.41mIU/L, mean 
FT4: 0.61 ± 0.02ng/dL), and 3 in the third trimester (mean TSH: 2.8 ± 0.34mIU/L, mean FT4: 
0.58 ± 0.06ng/dL).  
During 2004-2006 only two (1.1%) pregnant women in the third trimester presented low FT4 
among the 182 subjects with normal thyrotropin (mean TSH: 1.68mIU/L, mean FT4: 
0.63ng/dL).  
Thus, among the total number of 527 pregnant women 1.89% had isolated 
hypothyroxinaemia, mainly in the third trimester (half of the cases), when the upper normal 
limit of TSH-level is extended to 3.5mIU/L. In these latter cases the TSH-levels were situated 
mainly between 2.8-3.2 approaching to the upper normal limit in the III. trimester. 
5. Discussion 
During pregnancy the iodine requirement is increased by different mechanisms. One of 
these is the increase of maternal thyroxine secretion to maintain euthyroidism: the elevated 
TBG-level due to hyperestrogenism binds T4 in higher amounts as in non-pregnant 
conditions and must be saturated to obtain normal free thyroid hormone levels. At the same 
time, a part of iodine and maternal thyroid hormones are transferred to the fetus, 
particularly in later gestation. The other cause is the secretion of placental hCG (human 
chorionic gonadotropin), which stimulates thyroid hormone secretion (similarly with TSH) 
mainly near the end of the first trimester, and thus it can be associated with a transient 
lowering in serum TSH (Glinoer, 1999). Finally, a presumed cause of increased iodine 
requirement is the augmented renal iodine clearance in pregnancy (see Tabel 5).  
The iodine and the thyroid hormones are essential for the normal general development of 
offspring, especially for the differentiation of CNS, being indispensable for neuronal 
migration, arborization of dendrites, myelination of axons, normal synaptogenesis, synaptic 
transmission and plasticity during fetal and early postnatal life. The increased iodine and 
thyroid hormone requirement during pregnancy favours the development of iodine-
deficiency disorders (IDD) and of subsequent hypothyroidism, having serious consequences 
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on both maternal and fetal organisms, especially in conditions of reduced iodine supply in 
endemic regions. 
 
Causes Consequences
Hyperestrogenism elevated TBG-level and increased binding of 
thyroid hormones: for maintenance of 
euthyroidism maternal thyroxine secretion must be 
augmented 
Placental hCG  stimulates the thyroid hormone secretion 
Transplacental transfer primarily in the first trimester and in fetal 
hypothyroidism 
Increased renal iodine clearance urinary iodine losing 
Table 5. The causes of increased iodine requirement in pregnancy 
Iodine deficiency is still a health problem, not only worldwide but also in Europe. Recent 
French data show that in Northern Paris area the mean UIE was low (49.8µg/L), far under 
100µg/L, the formerly considered normal value (Luton et al., 2011). Taking into account that 
WHO currently recommends a median UIE in pregnant women of 150-249 µg/L, this result 
is still more alarming. Similarly, in the Lyon metropolitan area Raverot et al. (2012) found 
that pregnant women are iodine-deficient, 77% of them having a median UIE under 
150µg/L. 
In countries or regions where under 90% of households are using iodized salt and the 
median UIE in school-age children is under 100µg/L, WHO recommends iodine supplemen-
tation during pregnancy and infancy. Recently, WHO/UNICEF/ICCIDD increased the 
Recommended Nutrient Intake for iodine during pregnancy from 200 to 250μg/day and 
considered that the adequate iodine intake is reflected by a median UIE of 150-249μg/L 
(Zimmermann, 2009). In lactating women and children under the age of 2 years a median UIE of 
100μg/L can be used to define adequate iodine intake; although lactating women have the 
same requirement as pregnant women, the median urinary iodine is lower because iodine is 
also excreted in breast milk (WHO, 2007, see Table 6).  
 
Iodine dose 
(μg/day) Organization and date 
Median urinary iodine excretion 
(median UIE μg/L) 
200 
World Health Organization 1994; 
WHO/NUT/94.6,Geneva 
100 
250 WHO/UNICEF/ICCIDD 2007 150-249
Table 6. The evolution of recommended iodine intake during pregnancy 
WHO: World Health Organization; UNICEF: United Nations Children's Fund; ICCIDD: International 
Council for the Control of Iodine Deficiency Disorders 
In lactating women and children under the age of 2 years a median UIE of 100μg/L indicates adequate iodine 
intake; although lactating and pregnant women have the same iodine requirement, in formers the 
median UIE is lower due to iodine excretion in breast milk (WHO, 1994; 2007). 
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It is well known, that in severe iodine deficient regions maternal and fetal hypothyroidism 
can cause classic or masked cretinism or reduces cognitive development in children; to 
prevent fetal damage, iodine should be given before or in early pregnancy. During the 1st 
trimester, the fetus is completely dependent upon the thyroxine produced by the mother 
(Springer et al., 2011). 
A new USA trial has shown that when a hypothyroid woman becomes pregnant, she should 
immediately increase her levothyroxine dose by two tablets per week in order to remain 
biochemically euthyroid. This protocol significantly reduces the risk of maternal 
hypothyroidism during the first trimester and mimics normal physiology (Alexander et al., 
2004; Reuters Health Information 2010). It was previously reported that T4 requirement may 
rise as early as the fifth week of gestation (Alexander et al., 2004). In general, pregnant 
women started this protocol at a median of 5.5 weeks of pregnancy. Other authors 
recommended for women who became pregnant to increase the dose of levothyroxine by 30-
50%. Several authors would first check thyroid function tests before adjusting the dose 
(Vaidya et al., 2012). Thyroid hormone levels must be monitored at least every 4 week until 
20th weeks, because the required doses of T4 increase during pregnancy. The recommended 
control of thyroid hormone levels only at the 30th weeks of pregnancy may be considered 
insufficient, because in 92% of the cases were detected abnormal TSH values (Alexander et 
al., 2004; Reuters Health Information 2010). 
Our study shows that the targeted screening of high-risk pregnant women for thyroid 
dysfunctions according to the before mentioned inclusion criteria resulted the inclusion  
into the screening of only about 1/3 of pregnant women in the first gestational trimester 
(31.8% − 102 subjects from the 321 cases during 2001-2003), the others being detected  
only in the second or third trimester (39.2% in the II. and 29% in the III. trimester)  
according to symptoms, signs and/or gestational complications developed later during 
pregnancy. 
Early maternal iodine deficiency and hypothyroidism may cause developmental 
impairments in the fetal nervous system, but evidences about the consequences of later 
(after the first trimester) initiated thyroid hormone replacement therapy and of mild-to-
moderate iodine deficient maternal status are still limited. It is not clarified whether this 
mild maternal iodine deficiency can influence, and if so in what extent the cognitive 
function of offsprings. Studies showed impaired intellectual and motor development in 
children from endemic areas, but presumably other factors could affect mental 
development, too (Zimmermann, 2009).  
Taking into account that under the circumstances of targeted screening in high-risk 
pregnant women a large number of subjects are screened later, after the first gestational 
trimester, it is recommended to start thyroid hormone replacement as soon as possible. Thus 
the tendency to perform universal screening in early pregnancy for thyroid conditions, first 
of all in iodine deficient regions is justifiable.  
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Aggressive thyroid hormone replacement before or in early pregnancy is justified, but to 
recommend or discuss the possibility of therapeutic abortion in case of initiation the 
substitutive hormone therapy after the first trimester, because of fearing evident cognitive 
delay in offsprings, is not warranted (Downing et al., 2012). A quarter of the European 
thyroidologists recently responding to the electronic questionnaire survey of Vaidya et al. 
proved to have this opinion. In case of fetal hypothyroxinaemia it must be taken into 
account that there are also compensatory mechanisms that favour the transfer of thyroid 
hormones through placenta into the fetus. In this respect, it can be mentioned that according 
to a study the IQ of children born from mothers diagnosed with hypothyroidism during 
early pregnancy was normal, similarly to children born from mothers without thyroid 
hypofunction (Liu et al., 1994). 
The iodine state of a geographical area can be quantified by more indicators. Besides the 
screening of pregnant women using TSH and/or FT4, TPO-Ab assays, the serum TSH 
concentration in neonates measured in blood collected between the 3rd and 7th days of life is 
another indirect indicator. The incidence of cases with neonatal serum TSH>10mIU/L 
reflects the grade of iodine deficiency: between 3-19.9% indicates moderate, between 20-
39.9% severe and >40% very serious iodine deficiency (WHO, 1994; Delange, 1998). A 
frequency under 3% of TSH > 5mIU/L indicates iodine sufficiency.  
We obtained in the studied periods TSH>10mIU/L in 8-9% of newborns, indicating 
moderate iodine deficiency in Mureş County (Szántó et al., 2007). 
Other laboratory and imagistic parameters are urinary iodine excretion and thyroid 
ultrasound effectuated in school-children and pregnant women. 
The increased iodine and thyroid hormone requirement during pregnancy favours the 
development of hypothyroidism with consequences on both maternal and fetal organisms, 
and this may be aggravated in iodine deficient endemic regions. Since iodine deficiency is 
a continuous health problem worldwide, and knowing our region as a hilly-mountainous 
one, we have started to evaluate the iodine status of our county in the mirror of the 
criteria for iodine deficiency estimation (WHO, 1994). The studies realized on neonates 
and school-aged children cohorts have demonstrated that during 1990-2003 Mureş County 
was a moderately mild iodine deficient area (Kun et al., 2003; 2007; Kun, 2006) in the 
condition of relatively systematic iodine prophylaxis, but not rigorously controlled by 
legislative means. In that period of time iodized alimentary salt contained about 16mg KI 
per kg, and it was not mandatory to sell on market exclusively iodized alimentary salt. 
Simultaneously we started to evaluate pregnant women known with previous or present 
thyroid conditions and gestational complications, without the possibility of screening all 
pregnant women. Although, in recent recommendations living in an area with iodine 
insufficiency represents a risk factor for thyroid disorders in pregnant women (Stagnaro-
Green et al., 2011), so our endemic region represents increased risk factor during 
pregnancy. 
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In our study the rate of hypothyroidism in pregnant women with history of thyroid 
conditions or gestational complications, as well as signs/symptoms of thyroid dysfunction 
was 15.88% during 2001–2003, subclinical forms being diagnosed in 2/3 of cases. Gestational 
goiter was present in average 44.2% of the cohort and the randomly measured UIE showed 
reduced values in the majority of cases (88.6%), that suggest the insufficient prophylactic 
effect of the used iodized alimentary salt at that time (mean 16mg KI/kg salt). A proportion 
of 2.18% of high-risk pregnant women had hyperthyroidism. According to reported data 
thyroid dysfunction is observed in about 10% (0.4-25%) of pregnant women, its frequency 
being dependent on the severity of iodine-deficiency and the presence of thyroid antibodies. 
Our targeted screening of high-risk pregnant women has detected mainly subclinical 
hypothyroidism in the circumstances of moderately mild iodine deficiency before 2003. This 
mild form of thyroid dysfunction develops due to increased requirement of iodine and 
thyroid hormones during pregnancy and/or due to iodine deficiency and autoimmune 
lymphocytic thyroiditis (Badenhoop, 2000; Hehrmann, 2002). Anyway, the prevalence of 
Hashimoto’s thyroiditis in pregnancy is low, about 0.8–1% (Badenhoop, 2000), but it can 
increase during iodine prophylaxis, and this disease can also provoke gestational 
complications without any thyroid dysfunction (Negro et al., 2007; Thangaratinam et al., 
2011). In our cohort severe maternal and fetal complications developed in one case of 
chronic autoimmune thyroiditis and mild hypothyroidism, but we suppose that other 
factors might also contribute to this severe case of miscarriage (e.g. immunologic ones), 
taking into account that the grade of maternal hypothyroidism was mild. 
Neonates born to hypothyroid mothers presented almost significantly higher frequency of 
pre- or post-term delivery in comparison with the control group (newborns of apparently 
healthy mothers) − 25% vs. 7.7%. 
The screening and treatment of subclinical hypothyroidism in pregnancy have been 
recommended since 2001-2002 (Mann, 2001; Hehrmann, 2002), after the recognition of its 
role in development of maternal and fetal complications. Although subclinical 
hypothyroidism is a very mild thyroid dysfunction, it can favour both gestational/delivery 
and fetal complications (delay of central nervous system development and consecutive 
mental retardation). According to data reported by Abalovich in 2002 the frequency of both 
abortion and premature birth in inadequately treated pregnant woman with overt 
hypothyroidism was high (60% and 20%, respectively), but, surprisingly, the frequency of 
abortion in subclinical forms was much higher (above 70%). The rate of premature birth was 
7% in case of subclinical hypothyroidism. Under the condition of adequate T4-substitution of 
overt hypothyroidism 100%, but in state of subclinical form about 90% of pregnant women 
had normal termed delivery (Abalovich et al., 2002). Several studies showed that pregnancy 
was more likely to be complicated if subclinical hypothyroidism was present (Casey et al., 
2005; Pop et al., 2003). 
Other studies showed, that in course of pregnancy, the outcome of delivery and postpartum 
period, the neuromuscular development of newborns is mainly dependent on TPO-Ab level. 
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In pregnant women the frequency of increased TPO antibodies is about 9% (Hehrmann, 
2002). During 2001–2003 we could determine in our targeted screening the TPO-Ab-level in 
only 24 pregnant women, and we obtained elevated levels in 3 women. One of these three 
cases was diagnosed with Hashimoto-thyroiditis in the III. trimester, she developed high 
blood pressure, oedema, pre-eclampsia and premature birth, the new-born presenting 
severe asphyxia and died after birth. Data in the literature showed that from the second 
trimester onward, the major adverse obstetrical outcome associated with raised TSH was the 
increased rate of fetal death (Allan et al., 2000). The reduced number of TPO-Ab-positive 
cases in our cohort may be explained by immunsuppression during pregnancy: in the first 
trimester the level of antithyroid antibodies can increase, but after that TPO-Ab-level may 
decrease to the normal level until delivery.  
Iodine and thyroid hormone deficiency in the first trimester inhibits the development of the 
nervous system in the fetus, because the fetal organism is unable to produce sufficient 
amounts of thyroid hormones. Iodine deficiency in the precocious period of pregnancy 
conducts to the most severe neural impairments (mental retardation, dwarfism, 
neuromuscular complications, as spastic paresis of the limbs). These complications are 
irreversible, thus their prevention is indispensable. Later (II.-III. trimesters) may appear 
growth disturbances, but these are not irreversible. 
As our results show, during 2001-2003 the frequency of goiter increased gradually with 
gestational trimester. In the I. and II. trimester 40.2% and 42.1% of pregnant women had 
goiter, respectively, and this rate increased to 51.6% in the III. trimester. These results show 
indirectly the endemic character of our geographical area. 
After 2002, when the government decree took effect, universal iodine prophylaxis was 
applied with an increased iodine content alimentary salt (34±5mg/kg) and a more stable 
iodine salt (KIO3). Our targeted screening to detect thyroid dysfunction in pregnant women 
showed a decreasing tendency in the frequency of hypothyroidism (9.7%, P:0.049), being 
significantly reduced compared to the first period (15.88%), although, the distribution 
according to severity remained practically identical (subclinical forms in 50% vs. 40% in the 
first and second studied period of time). The ratio of overt:subclinical hypothyroidism 
remains almost unchanged during the two studied periods (1:2 vs. 2:3). The values of 
urinary iodine excretion of the two intervals did not differ significantly, in concordance with 
the similar data obtained in the whole country in 2004.  
Conversely, the frequency of hyperthyroidism had a slightly increasing tendency after 
universal iodine prophylaxis, but this change was not significant (2.18% in 2001-2003 vs. 
2.91% in 2004-2006). According to the literature the prevalence of hyperthyroidism in the 
United States is about 1%. The distribution of clinical and subclinical forms is almost 
equal: 0.4% overt and 0.6% subclinical forms. The activity level of autoimmune thyroid 
diseases may fluctuate during gestation, with exacerbation during the first trimester and 
gradual improvement during the later gestational period (The Endocrine Society’s 
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Clinical Guideline, 2007). Graves’ disease accounts for about 85% of hyperthyroidism 
during pregnancy. In autoimmune thyroiditis a hyperthyroid phase of Hashimoto's 
thyroiditis and silent thyroiditis may occur. The risk of complications for both mother and 
fetus is related to the duration and control of maternal hyperthyroidism. Inadequately 
treated maternal thyrotoxicosis is associated with increased risk of preterm delivery, 
which can occur in up to 88% of these pregnant women (The Endocrine Society’s Clinical 
Guideline, 2007). 
Iodine prophylaxis is needed in all pregnant women, not only for those living in endemic 
regions. In euthyroid (normal TSH-level), TPO-Ab-negative pregnant women without 
goiter, iodine usually must be applied in doses of 200-260µg/day. The use of iodine 
supplementation is also indicated in cases of elevated TPO-Ab-level, primarily for the fetus. 
We should also inform pregnant women that iodine overdose can induce hypothyroidism, 
so for detection repeated laboratory investigations may be necessary. This statement is also 
valid for the lactation period. 
In the treatment of endemic goiter, the increased need for iodine and thyroid hormones for 
both pregnant and fetus requires iodine administration (in the before mentioned doses) with 
or without association of T4-treatment (e.g. in doses of 50-75µg/day), the later alone being 
not sufficient during pregnancy. 
We must emphasize that in the II. trimester, the T4-level decreases and the TSH and the T3/T4 
ratio increase in one third of pregnant women. In this situation we must increase the T4 dose 
individually (but avoid the suppression of TSH). Generally, an adequate treatment of 
hypothyroidism needs increasing T4 doses as pregnancy progress. Thus, in early pregnancy 
we must monitor the thyroid hormone and TSH-levels frequently (e.g. on 10 days interval at 
the beginning, after that every 3-4 weeks during the first half of pregnancy, and monthly or 
every 6 weeks during the second half), to administer T4-preparations properly, in increasing 
doses.  
At the same time during pregnancy and lactation smoking and all medications with 
inhibitory effect on the thyroid function must be avoided. Among these iodine excess 
(iodinated contrast materials, amiodarone) must be emphasized. Iodine excess can induce 
not only hypothyroidism (through Wolff-Chaikoff effect), but also thyrotoxicosis 
(hyperthyroidism or subacute thyroiditis). These dysfunctions may appear both in mother 
and offspring (fetuses and neonates). The appearance of these adverse reactions depend on 
several factors, among them the iodine dose is very important. In this respect Kochi et al. 
(2012) show that there was no significant adverse clinical reaction of thyroid function 
abnormalities in the fetus after administering iv. iodinated contrast material to the mothers 
for computed tomography scan. In contrast, radioiodine administration is strictly 
contraindicated for both diagnostic and therapeutic purposes in pregnant women, because it 
can destroy the offspring's thyroid function. This rule is also valid in case of the thyroid 
cancer. When thyroid cancer is diagnosed during pregnancy, a decision must be taken 
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regarding performing thyroidectomy during the pregnancy or postponing surgical resection 
until the postpartum period. Radioactive iodine is absolutely contraindicated during 
pregnancy and lactation (Yazbeck & Sullivan, 2012). 
Isolated maternal hypothyroxinemia may have negative effects on motor, cognitive and 
neurobehavioural performance of the offspring, taking into account that maternal thyroxine 
plays a pivote role upon the normal nervous system development of the fetus. Screening of 
pregnant women for thyroid dysfunctions firstly measures TSH-levels, while free-T4 assays 
have limitations in clinical use. In these situations isolated maternal hypothyroxinemia may 
not be detected.  
The frequency of isolated maternal hypothyroxinemia and its impact on maternal/fetal 
complications, as well as therapeutical recommendations are not clarified entirely, yet. The 
incidence of this special hormonal state during pregnancy varies among wide intervals, 
depending on the iodine status of the geographical area, the trimester-specific hormonal 
assays and the used normal ranges, thus according to these influencing factors published 
data showed an incidence ranging between 1.3-26.5% (Casey et al., 2007; Vaidya et al., 2007; 
Clear-Goldman et al., 2008; Berbel et al., 2009; Moleti et al., 2009; Shan et al. 2009; Hendrichs 
et al., 2010). The prevalence is the lowest in the first gestational trimester (1.2-3.2%) but than 
it starts to increase gradually during the II. and III. trimesters reaching values as high as 
26.5% (Berbel et al., 2009). The true incidence of isolated maternal hypothyroxinemia is not 
known, yet. 
The influence of this state on pregnancy outcome and on fetal development is a question under 
debate. Some researchers have stated that isolated maternal hypothyroxinemia has no 
influence on obstetrical adverse outcomes (Casey et al., 2007), but further investigations in 
this respect are needed. It was reported, that isolated maternal hypothyroxinemia is 
associated with impaired neurodevelopment of offsprings (Pop et al., 1999), but this must 
also be confirmed by further surveys. 
The etiology of this state is also not known exactly. It was reported that in the circumstances 
of short-term iodine prophylaxis the prevalence of isolated hypothyroxinemia is 5-fold 
higher than in pregnant women who had regularly used iodized salt for at least 2 years 
before pregnancy occurred (36.8% versus 6.4%) (Moleti et al., 2011). It was suggested, that 
the cause of isolated hypothyroxinemia is iodine deficiency instead of autoimmune thyroid 
processes, such as among 56/220 (25.4%) pregnant women with isolated hypothyroxinemia 
TPO-Ab were detectable in only 7.1% of them (Moleti et al., 2009). Data published so far are 
not sufficient to recommend thyroxine replacement therapy in this case in pregnancy, 
although a study analysing questionnaires about the treatment of hypothyroidism during 
pregnancy filled in by over 600 members of the European Thyroid Society (ETA) showed 
that 38% of the responders would treat isolated maternal hypothyroxinemia, but the 
responders’ definition of this disorder was not consistent (Vaidya et al., 2012), which reflects 
the lack of clear definition and management of this state.  
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6. Conclusions 
During 2001-2003 the frequency of hypothyroidism in high-risk pregnant women was 
15.88% in Mureş County, a region with moderately mild iodine deficiency, the subclinical 
forms predominate versus overt hypothyroidism. During 2004-2006, after the 
implementation in practice of universal salt-iodization and more rigorous follow-up of 
thyroid dysfunctions the frequency of hypothyroidism in pregnancy decreased significantly 
(to 9.7%). Complications (imminent abortion, premature birth, gestational hypertension, 
pre-eclampsia) appeared with high frequency (in 50%) among hypothyroid pregnant 
women in the two periods of time. Special measures of iodine-prophylaxis are necessary in 
case of every pregnant woman, mainly for those living in endemic regions, because the 
universal salt-iodization (in our region iodized alimentary salt with 34 ± 8.5mg/kg KIO3) is 
not sufficient in all cases. Targeted screening could identify high-risk pregnant women in 
the first trimester only in 1/3 of cases, the others being detected later. Thus, our results plead 
for the necessity of universal screening of pregnant women for thyroid dysfunctions and their 
regular follow-up even in a mild iodine deficient area, taking into account that iodine 
deficiency, primarily through inducing hypothyroidism, can have detrimental effects on 
fetal brain development even from the first gestational trimester. Similarly, the early 
recognition and adequate treatment of thyroid disorders can contribute substantially to 
decrease of frequency and severity of other maternal and fetal complications related to these 
dysfunctions. 
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